Tongrentang is a long-established brand in China's traditional Chinese medicine industry. It was founded in 1669 and has a history of more than 300 years since then. In August 1992, China's Beijing Tongrentang Group Co., Ltd. was formally established. In June 1997, Beijing Tongrentang Co., Ltd. was solemnly listed and listed on the Shanghai Stock Exchange. In March 2000, Beijing Tongrentang Co., Ltd. lost some of its excellent assets to form Beijing Tongrentang Technology Development Co., Ltd., which was listed on the GEM of the Hong Kong Stock Exchange at the end of October of the same year. After listing, Tong Ren Tong Technology maintained good performance and was officially listed on the main board of the Hong Kong Stock Exchange on July 9, 2010, with the stock code 01666. As a high-tech modern traditional Chinese medicine enterprise under the Tongrentang Group that integrates production, supply and marketing, Tongrentang Technology insists on inheriting and carrying forward the Tongrentang royal pharmaceutical tradition, relies on modern pharmaceutical technology, takes “improving the health of the world” as its mission, adhering to the pharmaceutical characteristics of “unique formulations, excellent selection of ingredients, excellent craftsmanship, and remarkable curative effects”. All production workshops are designed, modified and operated in strict accordance with GMP standards. All production workshops are designed, modified and operated in strict accordance with GMP standards. It is famous for its large production potential, large dosage reserves, and good product quality. Not only have all production lines passed the national GMP certification, but we also have several that have passed Australia The production line certified by TGA and certified by the Ministry of Health and Welfare of Japan passed IS09001 quality system certification as early as 2003. Our company has purchased land in the Beijing Biomedical Industrial Park located in Daxing District, and invested in the construction of new logistics distribution centers, medicinal herb pre-treatment processing centers, and production centers for liquid formulations and softgels to further increase production capacity and guarantee market supply. The products of Beijing Tongrentang Technology Development Co., Ltd. cover more than 20 dosage forms, more than 200 varieties, and has a rich reserve of developed new products and new products under development. In recent years, according to market demand and changes, Beijing Tongrentang Technology Development Co., Ltd. has increased its product technology content and focused on secondary scientific research. It has introduced new products such as sugar-free production, fully extracted concentrated pill technology and tablet film coating, macroporous resin absorption, spray drying, fluid bed granulation, full extraction concentration, ultrafine grinding, etc., and launched new products such as sugar-free cold cooling granules, liuwei dihuang concentrate pills, various film-coated tablets, tablets, softgel dosage forms, etc., and has advanced tablets, softgels, concentrated pills, honey pills, etc. Production lines for pills and granules to meet the different needs of patients. It reflects Tong Ren Tang's business philosophy of pragmatism, seeking innovation, and putting patients first. In the future, Beijing Tongrentang Technology Development Co., Ltd. will continue to work to modernize traditional Chinese medicine, improve existing traditional Chinese medicine products and develop natural medicines, gradually modernize and internationalize traditional Chinese medicine, expand its marketing network, and promote the entry of modern traditional Chinese medicine into the mainstream international pharmaceutical market.
No Data
No Data